Advancing Design Strategy of PROTACs for Cancer Therapy

Advancing Design Strategy of PROTACs for Cancer Therapy

ABSTRACT Proteolysis targeting chimeras (PROTACs) have emerged as a groundbreaking class of anticancer therapeutics. These bifunctional molecules harness the endogenous ubiquitin–proteasome system to facilitate the degradation of targeted proteins of interest (POIs). Notably, the clinical translatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Hang Luo, Yuan Tian, Razack Abdullah, Baoting Zhang, Yuan Ma, Ge Zhang
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:MedComm
Subjects:
artificial intelligence
cancer therapy
E3 ligand
linker design
POI ligand
proteolysis targeting chimeras (PROTACs)
Online Access:https://doi.org/10.1002/mco2.70258
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://doi.org/10.1002/mco2.70258

Similar Items